WorldBI Interviews

Interview with GlobalVision

With sustainability in mind, how does GlobalVision help reduce reprints and material waste?

GlobalVision’s automated proofreading and quality control platform pinpoints errors in text, graphics, barcodes, braille, and color before packaging goes to print, helping pharmaceutical teams catch discrepancies early in the workflow. By identifying issues upfront, we empower companies to avoid costly reprints and significantly cut down on material waste, supporting both sustainability and operational efficiency. Our advanced inspection tools ensure that only accurate, approved content moves forward-so nothing is wasted on preventable mistakes—helping both pharmaceutical companies as well as their suppliers mitigate their carbon footprint.

What role does automation play in reducing human error in pharma document reviews?

Automation is at the core of GlobalVision’s approach. Our software compares files with pixel-to-pixel and character-to-character accuracy, eliminating the manual bottlenecks and risks of oversight that come with traditional proofreading. By automating inspections for text, graphics, braille, and barcodes - including medical terms and multilingual content - GlobalVision enables pharma teams to maintain the highest standards of quality and compliance, while freeing up valuable time for strategic work.

Your automated proofreading tools are widely used - what impact have they had on reducing errors in pharma packaging?

GlobalVision is trusted by leading pharmaceutical companies worldwide to safeguard packaging accuracy. Our platform has helped clients reduce artwork and labeling errors, minimize recalls, and accelerate time-to-market by streamlining quality checks. As one customer from Pfizer noted, “GlobalVision provides an integrated system that is technologically advanced and sophisticated, allowing for fast analysis… the system is extremely user-friendly and the support and training made the transition seamless”. This translates into fewer errors, consumer and patient safety protection, and consistent regulatory compliance.

How does GlobalVision stay ahead of evolving regulatory demands in the life sciences industry?

GlobalVision’s platform is continuously updated to reflect the latest regulatory requirements. Our tools are designed to help companies maintain compliance across all markets, with comprehensive audit trails and reporting features that support transparency and data integrity. By leveraging cloud-based technology and AI-driven enhancements, we ensure our clients are always equipped to meet new regulatory challenges head-on.

How does GlobalVision help pharmaceutical companies ensure label accuracy and regulatory compliance?

Our all-in-one inspection platform verifies every element of a label - text, graphics, barcodes, braille, and even font sizing. GlobalVision’s advanced comparison and proofreading tools catch even the smallest discrepancies, while built-in medical and custom dictionaries help teams maintain accuracy with industry-specific terminology. Comprehensive reporting and electronic signatures streamline approvals, ensuring every label meets compliance standards before reaching the market.

How do you see the Pharma Packaging & Labelling Forum 2025 as a platform for collaboration and innovation within the industry, and what impact do you hope it will have on future partnerships or product development for GlobalVision?

The Forum is an ideal setting to connect with industry leaders who share our passion for quality, compliance, and innovation. We look forward to exchanging ideas, exploring new trends in packaging and labeling, and building partnerships that drive continuous improvement. These conversations inspire us to refine our solutions and anticipate the evolving needs of the pharma sector, ensuring GlobalVision remains at the forefront of quality control technology.